These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 12018679)

  • 1. Anti-HIV-1 activity of benzothiadiazine dioxide.
    Martinez A; Gil C; Castro A; Perez C; Witvrouw M; Pannecouque C; Balzarini J; De Clercq E
    Antivir Chem Chemother; 2001 Nov; 12(6):347-51. PubMed ID: 12018679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzothiadiazine dioxides (BTD) derivatives as non-nucleoside human cytomegalovirus (HCMV) inhibitors. study of structural requirements for biological activity.
    Martinez A; Gil C; Castro A; Pérez C; Prieto C; Otero J
    Bioorg Med Chem; 2003 May; 11(11):2395-402. PubMed ID: 12735985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonnucleoside human cytomegalovirus inhibitors: synthesis and antiviral evaluation of (chlorophenylmethyl)benzothiadiazine dioxide derivatives.
    Martinez A; Gil C; Perez C; Castro A; Prieto C; Otero J; Andrei G; Snoeck R; Balzarini J; De Clercq E
    J Med Chem; 2000 Aug; 43(17):3267-73. PubMed ID: 10966745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzothiadiazine dioxide human cytomegalovirus inhibitors: synthesis and antiviral evaluation of main heterocycle modified derivatives.
    Martinez A; Gil C; Castro A; Bruno AM; Pérez C; Prieto C; Otero J
    Antivir Chem Chemother; 2003 Mar; 14(2):107-14. PubMed ID: 12856922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel potential agents for human cytomegalovirus infection: synthesis and antiviral activity evaluation of benzothiadiazine dioxide acyclonucleosides.
    Martinez A; Esteban AI; Castro A; Gil C; Conde S; Andrei G; Snoeck R; Balzarini J; De Clercq E
    J Med Chem; 1999 Apr; 42(7):1145-50. PubMed ID: 10197958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Good oral absorption prediction on non-nucleoside benzothiadiazine dioxide human cytomegalovirus inhibitors using combined chromatographic and neuronal network techniques.
    Gil C; Dorronsoro I; Castro A; Martinez A
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1919-21. PubMed ID: 15780633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in antiviral activity of benzo/heterothiadiazine dioxide derivatives.
    Zhan P; Liu X; De Clercq E
    Curr Med Chem; 2008; 15(15):1529-40. PubMed ID: 18537628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorophenylmethyl benzothiadiazine dioxides derivatives: potent human cytomegalovirus inhibitors.
    Martinez A; Gil C; Perez C; Castro A; Prieto C; Otero J
    Bioorg Med Chem Lett; 1999 Nov; 9(21):3133-6. PubMed ID: 10560739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzothiadiazine dioxide dibenzyl derivatives as potent human cytomegalovirus inhibitors: synthesis and comparative molecular field analysis.
    Martinez A; Gil C; Abasolo MI; Castro A; Bruno AM; Perez C; Prieto C; Otero J
    J Med Chem; 2000 Aug; 43(17):3218-25. PubMed ID: 10966740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel [2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]- 3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2" -dioxide) derivatives with anti-HIV-1 and anti-human-cytomegalovirus activity.
    de Castro S; Lobatón E; Pérez-Pérez MJ; San-Félix A; Cordeiro A; Andrei G; Snoeck R; De Clercq E; Balzarini J; Camarasa MJ; Velázquez S
    J Med Chem; 2005 Feb; 48(4):1158-68. PubMed ID: 15715482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and antiviral activity of 1,3-disubstituted uracils against HIV-1 and HCMV.
    Maruyama T; Kozai S; Yamasaki T; Witvrouw M; Pannecouque C; Balzarini J; Snoeck R; Andrei G; De Clercq E
    Antivir Chem Chemother; 2003 Sep; 14(5):271-9. PubMed ID: 14694990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiviral activity of 3-(3,5-dimethylbenzyl)uracil derivatives against HIV-1 and HCMV.
    Maruyama T; Demizu Y; Kozai S; Witvrouw M; Pannecouque C; Balzarini J; Snoecks R; Andrei G; De Clercq E
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(10-12):1553-8. PubMed ID: 18066825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity.
    Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW
    Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action.
    de Castro S; Peromingo MT; Naesens L; Andrei G; Snoeck R; Balzarini J; Velázquez S; Camarasa MJ
    J Med Chem; 2008 Sep; 51(18):5823-32. PubMed ID: 18707089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Senseless" antiviral polyribonucleotides: poly (1-propargylinosinic acid).
    Hyde RM; Buckheit RW; Broom AD
    Nucleosides Nucleotides Nucleic Acids; 2002; 21(1):45-54. PubMed ID: 11995639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of novel difluoro-cyclopropyl guanine nucleosides and their phosphonate analogues as potent antiviral agents.
    Li H; Yoo JC; Kim E; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2011 Nov; 30(11):945-60. PubMed ID: 22060557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral activities against HSV-1, HCMV, and HIV-1 of rhamnan sulfate from Monostroma latissimum.
    Lee JB; Hayashi K; Hayashi T; Sankawa U; Maeda M
    Planta Med; 1999 Jun; 65(5):439-41. PubMed ID: 10418331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors.
    Corbett JW; Gearhart LA; Ko SS; Rodgers JD; Cordova BC; Klabe RM; Erickson-Viitanen SK
    Bioorg Med Chem Lett; 2000 Jan; 10(2):193-5. PubMed ID: 10673109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and evaluation of WC5 analogues as inhibitors of human cytomegalovirus Immediate-Early 2 protein, a promising target for anti-HCMV treatment.
    Massari S; Mercorelli B; Sancineto L; Sabatini S; Cecchetti V; Gribaudo G; Palù G; Pannecouque C; Loregian A; Tabarrini O
    ChemMedChem; 2013 Aug; 8(8):1403-14. PubMed ID: 23757191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design and synthesis of novel 1',3'-dioxolane 5'-deoxyphosphonic acid purine analogues as potent antiviral agents.
    Kim E; Liu LJ; Lee W; Hong JH
    Nucleosides Nucleotides Nucleic Acids; 2012; 31(2):85-96. PubMed ID: 22303989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.